Falahatkar Reza, Falahatkar Siavash, Khajavi Gaskarei Mohammad Amin, Afzalipoor Masoomeh, Mojtahedi Ali, Aligolighasemabadi Neda, Deilami Ahmad, Mirzaei Dahka Samaneh, Keivanlou Mohammad-Hossein, Jafari Alireza
Urology Research Center, Guilan University of Medical Sciences, Guilan, Rasht, Iran.
Department of Surgery, University of Saskatchewan, Saskatoon, Canada.
Asian J Urol. 2024 Apr;11(2):253-260. doi: 10.1016/j.ajur.2022.04.008. Epub 2023 Apr 11.
This study aimed to explore the global, prevalence, and risk factors of fever after percutaneous nephrolithotomy (PCNL) by conducting a systematic review and meta-analysis.
The high-sensitivity searching was conducted without time limitation until December 30, 2020 in Web of Sciences, Scopus, and PubMed based on inclusion and exclusion criteria.
The prevalence rates of fever and sepsis among patient undergoing PCNL were estimated 9.5% (95% confidence interval [CI]: 9.3%-9.7%), and 4.5% (95% CI: 4.2%-4.8%), respectively. Nephrostomy tube was used in 9.96% (95% CI: 9.94%-9.97%) of patients. The mean preoperative white blood cells of patients were 6.401×10/L; 18.3% and 4.55% of patients were considered as the positive urinary culture and pyuria, respectively. About 20.4% of patients suffered from residual stones. The odds ratios (ORs) of fever in patients who suffering from diabetes mellitus, hydronephrosis, staghorn stones, and blood transfusion were 4.62 (95% CI: 2.95-7.26), 1.04 (95% CI: 0.81-1.34), 2.57 (95% CI: 0.93-7.11), and 2.65 (95% CI: 1.62-4.35), respectively. Patients who underwent PCNL in prone position were more likely to develop fever (OR: 1.23; 95% CI: 0.75-2.00) than patients in supine position.
The current study showed that patients who suffer from diabetes mellitus, hydronephrosis, staghorn stones, nephrostomy tube or double-J stent, blood transfusion, and also patients who underwent PCNL in prone position surgery are more likely to develop a postoperative fever after PCNL.
本研究旨在通过系统评价和荟萃分析,探讨经皮肾镜取石术(PCNL)后发热的全球发病率、患病率及危险因素。
根据纳入和排除标准,于2020年12月30日前在Web of Sciences、Scopus和PubMed中进行无时间限制的高灵敏度检索。
接受PCNL的患者中发热和脓毒症的患病率分别估计为9.5%(95%置信区间[CI]:9.3%-9.7%)和4.5%(95%CI:4.2%-4.8%)。9.96%(95%CI:9.94%-9.97%)的患者使用了肾造瘘管。患者术前白细胞平均为6.401×10/L;分别有18.3%和4.55%的患者尿培养阳性和有脓尿。约20.4%的患者有残余结石。患有糖尿病、肾积水、鹿角形结石和输血的患者发热的比值比(OR)分别为4.62(95%CI:2.95-7.26)、1.04(95%CI:0.81-1.34)、2.57(95%CI:0.93-7.11)和2.65(95%CI:1.62-4.35)。与仰卧位患者相比,俯卧位接受PCNL的患者更易发热(OR:1.23;95%CI:0.75-2.00)。
当前研究表明,患有糖尿病、肾积水、鹿角形结石、使用肾造瘘管或双J支架、输血的患者,以及在俯卧位进行PCNL手术的患者,PCNL术后更易发热。